Asia Pacific Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

List of Tables

The intradermal injections market in Asia Pacific is expected to grow from US$ 774.05 million in 2021 to US$ 1,698.43 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2021 to 2028.

Developed and Developing Countries Provide Significant Growth Opportunities to Market

Health systems in developing economies focus on introducing various advanced therapeutic, diagnostic, and aesthetic technologies into their service portfolios to be able to provide healthcare facilities with high efficiency. In developed countries, intradermal devices have received significant acceptance in vaccination and cosmetic procedures. In developing countries, although these devices are mainly used in vaccination, tuberculosis diagnosis, and aesthetic procedures, the market is currently in a nascent stage of development. Many developing countries are attractive destinations for medical tourism, especially for aesthetic procedures due to the lower costs of these procedures than developed countries. Health facilities, medical spas, and wellness centers in developing countries are increasingly offering a comprehensive range of inexpensive but high-quality medical-aesthetic procedures, which, eventually, triggers the demand for intradermal injections. The leading manufacturers of intradermal injections are developing ideal devices and collaborating with other players to improve the therapeutic efficacy of existing and new drugs. Asia Pacific is expected to be the fastest-growing market for intradermal injections among all major regions, with countries such as China, Japan, India, and South Korea being prime contributors to the market growth, during the forecast period. The rapid pace of urbanization, surging investments by healthcare providers in improving infrastructure, growing awareness among the population, and increasing availability of a range of advanced products and technologies are all contributing to the growth of this market.

Market Overview

The Asia Pacific intradermal injections market is segmented into Australia, China, India, Japan, South Korea, and Rest of Asia Pacific. The market growth in the region is ascribed to the growing investments from international players in China and India with greater government support, expanding base of CRO service providers, and advancements in healthcare infrastructure. The medical device industry in China has grown at a faster pace in the past several years. This growth can be attributed to China's 13th Five-Year Plan that prioritizes health and innovation, increased demand for technologically advanced medical devices, significantly rising geriatric population, and growing chronic health conditions among people. In addition, the availability of low-cost and skilled laborers and massive space for production facilities have encouraged various market leaders to have their production plants in China. The Population Reference Bureau has projected that 366 million people in China will be aged 65 or more by 2050. Per the WHO's Ageing and Health in China, in 2019, ~75% of people with age 60 and above suffered from noncommunicable diseases, such as cardiovascular disease, diabetes, and hypertension. The R&D sector of China is focused on develop devices for painless delivery of drugs via intradermal route, which can specifically of help during the procedures involving elderly populations.

Asia Pacific Intradermal Injections Market Segmentation

The Asia Pacific intradermal injections market is segmented on the basis of method, application, end user, and country.

Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further subsegmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors.

In terms of application, the Asia Pacific intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021.

The Asia Pacific intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021.

Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and rest of Asia Pacific. China dominated the market share in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the Asia Pacific region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific intradermal injections market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPRE00027984

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 APAC Intradermal Injections Market - By Method
- 1.3.2 APAC Intradermal Injections Market - By Application
- 1.3.3 APAC Intradermal Injections Market - By End User
- 1.3.4 APAC Intradermal Injections Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. APAC Intradermal Injections Market Landscape

4.1 Overview
4.2 APAC PEST ANALYSIS
4.3 EXPERT OPINIONS

5. APAC Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Intradermal Vaccination
- 5.1.2 Increasing Incidences of diseases
- 5.1.3 Rising Acceptance of Aesthetic Procedures
5.2 Key Market Restraints
- 5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
5.3 Key Market Opportunities
- 5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
5.4 Future Trends
- 5.4.1 Strategic Developments by Manufacturers
5.5 Impact Analysis of Drivers and Restraints

6. Intradermal Injections Market- APAC Analysis

6.1 APAC Intradermal Injections Market, By Country - Forecast and Analysis

7. APAC Intradermal Injections Market Revenue And Forecasts To 2028- By Method

7.1 Overview
7.2 APAC Intradermal Injections Market, By Method, 2021 & 2028 (%)
7.3 Normal-Sized Needles (MANTOUX)
- 7.3.1 Overview
- 7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
7.4 Short Needles
- 7.4.1 Overview
- 7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Intradermal Microinjection
  - 7.4.3.1 Overview
  - 7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Microneedle Arrays
  - 7.4.4.1 Overview
  - 7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Tattoo Devices
  - 7.4.5.1 Overview
  - 7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5 Without Needles
- 7.5.1 Overview
- 7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.5.3 Intradermal Liquid Jet Injectors
  - 7.5.3.1 Overview
  - 7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.5.4 Ballistic Intradermal Injectors
  - 7.5.4.1 Overview
  - 7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. APAC Intradermal Injections Market Revenue and Forecasts To 2028 - Application

8.1 Overview
8.2 APAC Intradermal Injections Market Share by Application - 2021 & 2028 (%)
8.3 Tuberculin Skin Testing
- 8.3.1 Overview
- 8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Allergy Testing
- 8.4.1 Overview
- 8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Local Aesthetics
- 8.5.1 Overview
- 8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
8.6 OTHERS
- 8.6.1 Overview
- 8.6.2 Others Market Forecast and Analysis

9. APAC Intradermal Injections Market Analysis - End User

9.1 Overview
9.2 APAC Intradermal Injections Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
- 9.5.1 Overview
- 9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.6 OTHERS
- 9.6.1 Overview
- 9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. APAC Intradermal Injections Market Revenue and Forecasts To 2028 - Country Analysis

10.1 Asia Pacific Intradermal Injections Market Revenue and Forecasts To 2028
- 10.1.1 Overview
- 10.1.2 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  - 10.1.2.1 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.1.3 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.2.1.3.1 Japan: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.2.1.3.2 Japan: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.2.1.4 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.1.2.1.5 Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.2.3 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.2.2.3.1 China: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.2.2.3.2 China: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.2.2.4 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.1.2.2.5 China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.3 India Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.3.3 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.2.3.3.1 India: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.2.3.3.2 India: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.2.3.4 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.1.2.3.5 India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.4.3 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.2.4.3.1 South Korea: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.2.4.3.2 South Korea: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.2.4.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.1.2.4.5 South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.5 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.2.5.3 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.2.5.3.1 Australia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.2.5.3.2 Australia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.2.5.4 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.1.2.5.5 Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.2.6 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.3 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.2.6.3.1 Rest of Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.2.6.3.2 Rest of Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.2.6.4 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.1.2.6.5 Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Developments
- 11.2.1 Overview

12. Company Profiles

12.1 BD
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 West Pharmaceutical Services, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Terumo Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 NanoPass
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pharmajet
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Idevax
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 EUNSUNG GLOBAL
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Crossject
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Cardinal Health Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Hindustan Syringes and Medical Devices Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms